我国药品召回制度的经济学分析

Drug Recall System:Economics' Analysis

药品召回制度是国际上盛行的一种药品市场管理制度,但是,在我国,相关制度安排却还有很多的不足之处,一般性的法律规范到现在还没出台。由于权利安排不明晰,消费者没有拒绝缺陷药品的权利,福利遭受损失。同时,厂商也面临承担巨大成本的风险,社会效率受损。通过改变制度安排,实施缺陷药品召回,以此来鼓励和约束厂商行为,在保障消费者福利最大化的同时降低企业成本,以实现社会资源的最优配置。

Drug Recall system is prevalent in the international drug market man- agement system,but there is not a general law or regulation on drug recall estab- lished in China.Due to lacking of clarity rights arrangements,consumers have not the right to refuse defect drugs,their welfare declines.Meanwhile,manufacturers have to bear the enormous costs facing the risk of damage to social efficiency.By changing the arrangements,establishing the system Defects Drug Recall,encour- aging and binding manufacturers、behavior,the state of consumers'welfare the manufacturer' s Costs will decline will become better,social resources will achieve the optimal allocation.